These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7413014)

  • 41. Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group.
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):412-5. PubMed ID: 3283297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [HLA-DRW antigens and multiple sclerosis].
    De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.
    Lamoureux G; Duquette P; Lapierre Y; Cosgrove B; Bourret G; Labrie L
    J Neurol; 1983; 230(2):91-104. PubMed ID: 6196464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple sclerosis in 3 gipsy and 2 partly gipsy subjects (a clinical and immunogenetic study).
    Pálffy G; Gyódi E; Petrányi G
    Acta Med Hung; 1986; 43(1):31-7. PubMed ID: 3774417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased frequency of HLA--DRw2 and DRw3 in multiple sclerosis.
    de Moerloose P; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Tissue Antigens; 1979 May; 13(5):357-60. PubMed ID: 91212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA and multiple sclerosis: population and families study.
    Govaerts A; Gony J; Martin-Mondiére C; Poirier JC; Schmid M; Schuller E; Degos JD; Dausset J
    Tissue Antigens; 1985 Apr; 25(4):187-99. PubMed ID: 3874450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sporadic and familial-occurring multiple sclerosis. HLA typing and study of chromosomal sister chromatid exchange rate].
    Träder JM; Warecka K; Schwinger E
    Fortschr Neurol Psychiatr; 1985 Apr; 53(4):134-7. PubMed ID: 3997038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence of multiple sclerosis in south east Wales.
    Swingler RJ; Compston DA
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1520-4. PubMed ID: 3265431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenetic profile of multiple sclerosis in Mexicans.
    Gorodezky C; Najera R; Rangel BE; Castro LE; Flores J; Velázquez G; Granados J; Sotelo J
    Hum Immunol; 1986 Aug; 16(4):364-74. PubMed ID: 3093412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of antigen-specific T cells in multiple sclerosis twins with elevated proliferative responses to measles virus.
    Greenstein JI; McFarland HF; Richert JR
    J Immunol; 1986 Jul; 137(2):546-50. PubMed ID: 2424972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [HLA and familial multiple sclerosis].
    Barroche G; Perrier P; Raffoux C; Gehin P; Streiff F; Weber M
    Rev Neurol (Paris); 1986; 142(10):738-45. PubMed ID: 3823705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of 39 cases of multiple sclerosis (MS) including 2 familial cases. Leukocyte migration inhibition test in the presence of measles antigen with and without levamisole. HL-A typing (SD)].
    Hainaut J; Ribot C; Lefebvre P; Goasguen J; Piette JP
    Ann Med Interne (Paris); 1977 Oct; 128(10):767-72. PubMed ID: 931233
    [No Abstract]   [Full Text] [Related]  

  • 57. Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis.
    Ewan PW; Lachmann PJ
    Clin Exp Immunol; 1977 Oct; 30(1):22-31. PubMed ID: 304777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Multiple sclerosis: advances in its pathogenesis].
    Godoy J; Court J
    Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
    [No Abstract]   [Full Text] [Related]  

  • 59. [HLA and multiple sclerosis. Studies of a spanish population].
    Uría DF
    Rev Neurol; 2000 Dec 1-15; 31(11):1066-70. PubMed ID: 11190875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M; Fauchet R; Oger J; Sabouraud O
    Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.